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The heptad repeat (HR), a conserved structural motif of class I viral fusion proteins, is responsible for the
formation of a six-helix bundle structure during the envelope fusion process. The insect baculovirus F protein
is a newly found budded virus envelope fusion protein which possesses common features to class I fusion
proteins, such as proteolytic cleavage and the presence of an N-terminal open fusion peptide and multiple HR
domains on the transmembrane subunit F1. Similar to many vertebrate viral fusion proteins, a conserved
leucine zipper motif is predicted in this HR region proximal to the fusion peptide in baculovirus F proteins.
To facilitate our understanding of the functional role of this leucine zipper-like HR1 domain in baculovirus F
protein synthesis, processing, and viral infectivity, key leucine residues (Leu209, Leu216, and Leu223) were
replaced by alanine (A) or arginine (R), respectively. By using Autographa californica multicapsid nucleopoly-
hedrovirus (AcMNPV) as a pseudotype expression system, we demonstrated that all mutant F proteins
incorporated into budded virus, indicating that leucine substitutions did not affect intercellular trafficking of
F. Furin-like protease cleavage was not affected by any of the leucine substitutions; however, the disulfide
bridging and N-linked glycosylation patterns were partly altered. Single substitutions in HR1 showed that the
three leucine residues were critical for F fusogenicity and the rescue of AcMNPV infectivity. Our results
support the view that the leucine zipper-like HR1 domain is important to safeguard the proper folding,
glycosylation, and fusogenicity of baculovirus F proteins.
Baculoviridae is a large family of enveloped DNA viruses
that are pathogenic to arthropods, predominantly insects in the
order Lepidoptera (46). Baculoviruses are divided into two
genera, Nucleopolyhedrovirus and Granulovirus. Phylogenetic
studies indicate that nucleopolyhedroviruses (NPVs) can be
divided into two subgroups, group I and group II (21, 56).
Baculoviruses produce two distinct virion phenotypes: occlu-
sion-derived virus (ODV) and budded virus (BV) (48). ODVs
are present in occlusion bodies and are able to infect midgut
epithelial cells by direct membrane fusion. In contrast, BVs are
adapted to propagate infection from cell to cell and enter via
clathrin-mediated endocytosis (29, 48). BVs are responsible for
the systemic spread of the virus in the infected insect and
infected insect cell cultures.
Viral envelope fusion proteins can be sorted into at least two
distinct classes, class I and class II, based on their functional
characteristics (16). Class I fusion proteins are found in many
disparate RNA virus families, including retroviruses, ortho-
myxoviruses, paramyxoviruses, arenaviruses, coronaviruses,
and filoviruses. Viral fusion proteins of alphaviruses and flavi-
viruses have been categorized as class II (16). In the case of
baculoviruses, two distinct envelope fusion proteins were
found in BVs, GP64 for group I NPVs (4) and F for group II
NPVs (23, 28, 38). F proteins from group II NPVs are func-
tional analogs to GP64 (28, 30, 32), as both entire and cyto-
plasmic tail-truncated F genes can rescue the infectivity of a
gp64-null Autographa californica multicapsid nucleopolyhedro-
virus (AcMNPV) (30). Group I NPVs contain a remnant F
gene (Ac23 like) whose product is associated with BVs but has
no fusogenic activity (33).
Unlike GP64, baculovirus F proteins have been shown to
possess structural characteristics similar to class I fusion pro-
teins from vertebrate viruses. F proteins are synthesized first as
a proprotein and are later cleaved by a furin-like protease (Fig.
1), resulting in two disulfide-linked subunits, F1 (C terminal)
and F2 (N terminal) (28, 52). Baculovirus F proteins are N-
glycosylated and are found as homotrimers on the BV particle
(28). A putative fusion peptide located on the N terminus of
the F1 subunit was reported to be critical to the biological
function of Spodoptera exigua MNPV F (51). Furthermore,
heptad repeat (HR) regions were predicted in baculovirus F
proteins, with HR1 downstream of the fusion peptide region
and HR2 upstream of the transmembrane domain (Fig. 1 and
2). In contrast to GP64 and despite their structural homology
to vertebrate virus F proteins, group II NPVs are unable to
infect mammalian cells. It is therefore important to study the
characteristics of baculovirus F proteins, more specifically the
domains that are related to F-structure and function, such as
HRs.
HR motifs have the ability to form amphipathic helices and
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have been detected in the transmembrane subunit of the class
I viral envelope fusion proteins of RNA viruses (13). They have
been shown to play an essential role in viral fusion and infec-
tivity (9, 12, 14, 20, 34, 41, 43, 50). After receptor binding or
induction by low pH, the trimeric viral fusion proteins undergo
a series of conformational changes in order to allow fusion to
occur (2, 7, 14, 16, 45). X-ray crystallographic studies of various
viral fusion protein transmembrane subunits demonstrated
that HR regions form coiled-coil trimer or six-helix bundle
structures, whereby three HR1 helices form a central coiled-
coil surrounded by three HR2 helices in an antiparallel orien-
tation (8, 10, 25, 27, 35, 36, 49, 55, 57). Peptides derived from
HRs were reported to be potent and specific inhibitors of
membrane fusion and viral infection (5, 11, 19, 37, 42, 53).
Similar to many vertebrate viral envelope fusion proteins (1,
7, 12, 14, 34, 41, 54), an HR region with a leucine zipper-like
motif (HR1) was located downstream of the fusion peptide of
baculovirus (HearNPV) F (Fig. 1), but its role in baculovirus F
functioning was not explored. To promote further understand-
ing of the fusion process mediated by F in insect cells and the
functional role of the proximal HR1, mutations were intro-
duced into the predicted leucine zipper-like motif within HR1.
This was done by replacing key leucines (Leu209, Leu216, and
Leu223) of the zipper with alanine (nonpolar) or arginine
(positively charged). A gp64-null AcMNPV bacmid pseudotyp-
ing system (32) and the conventional AcMNPV insect cell
expression system were combined to test the effects of the
substitutions on the characteristics of F protein expression and
F function, including the potential to rescue gp64-null AcMNPV
and to mediate low-pH-activated membrane fusion. The
present study suggests that the conserved leucines located in
the HR1 domain play an essential role in baculovirus F pro-
tein-mediated membrane fusion and viral infectivity by bring-
ing the protein into the optimal conformation to allow proper
folding and glycosylation.
MATERIALS AND METHODS
Cells and bacmid. Spodoptera frugiperda cell line IPLB-SF-21 (47) and Sf9Op1D
cells (40) were cultured at 27°C in plastic tissue culture flasks (Nunc) in Grace’s
insect medium (pH 5.9 to 6.1; Invitrogen) supplemented with 10% fetal bovine
serum (FBS). A gp64-null bacmid (32) was used to study the functional role of
the HR1 region of the HearNPV F protein.
Computational analysis. The sequence for the HearNPV F protein was ob-
tained from GenBank (AF271059). Predictions of potential coiled-coil regions
(Paircoil) and transmembrane domains (TMHMM) were conducted by using
proteomic tools of the Expasy Proteomics server (http://us.expasy.org).
Mutagenesis and bacmids. Site-directed mutagenesis of the selected leucines
was performed as follows (Fig. 2). Preferred codons (underlined) of the small
uncharged residue alanine (A) and charged residue arginine (R) replaced the
codons for Leu209, Leu216, and Leu223 by introducing in the 5 end of mu-
tagenesis reverse primers (R-L209R, 5-ACGCGCGTTGTTATTTTTGGCT
AAAG-3; R-L209A, 5-CGCCGCGTTGTTATTTTTGGCTAAAG-3;
R-L216R, 5-ACGTTCTTTCACTTGTTCGTTGAGC-3; R-L216A, 5-CGCT
TCTTTCACTTGTTCGTTGAGC-3; R-L223R, 5-ACGACGTATGAGTTCA
TCGTCGAGTTC-3; and R-L223A, 5-CGCACGTATGAGTTCATCGTCGA
GTTC-3). With prior 5 phosphorylation of the reverse primers and three
forward primers (F-L209, 5-ACCGAACAAGTGAAAGAACTCGAC-3;
F-L216, 5-GACGATGAACTCATACGTTTGGTC-3; and F-L223, 5-GTCA
ACTATGAAGATCATTTGG CGT-3), PCRs were performed with a template
vector, pFB-F&GFP (29), a pFAST-BAC vector carrying the HearNPV f gene
under control of its native promoter, and the gfp gene under control of AcMNPV
p10 promoter. Phusion polymerase (Finzyme) was applied in the PCR. After the
first purification, the mutant PCR products were treated with DpnI to eliminate
template plasmid DNA. Subsequently, the 5 ends of purified PCR products were
ligated to their own 3 ends, generating new plasmids containing the site-directed
mutant sequences in HearNPV F. After sequence verification, the mutant F gene
cassettes were cloned back into the pFB-F&GFP vector to replace the wild-type
HearNPV f gene cassette by swapping the Bst1107I-to-HindIII fragments. This
resulted in donor plasmids each carrying one of the six mutant f genes. These
donor plasmids were used to transpose six mutant f genes into a gp64-null
AcMNPV bacmid and into a wild-type AcMNPV bacmid containing the GP64
gene as well.
Competent cells containing either the gp64-null AcMNPV bacmid or the
wild-type AcMNPV bacmid were made according to the methods described in
the Bac-to-Bac manual (Invitrogen). Transpositions of site-directed mutant
genes from donor plasmids to either gp64-null AcMNPV bacmid or wild-type
AcMNPV bacmid were confirmed by diagnostic PCR using a forward primer
(5-AGCCACCTACTCCCAACATC-3) from the gentamicin resistance gene in
FIG. 1. Amino acid sequence alignment of the HearNPV F protein domains near the N-terminal heptad repeat, HR1, with the corresponding
domain of F homologous proteins of group II NPVs, GVs, and group I NPVs. Virus abbreviations are shown on the left (see also reference 46).
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combination with the M13 forward primer (5-CCCAGTCACGACGTTGTAA
AACG-3). Transfection and infection assays were conducted according to the
methods of Long et al. (30).
Transfection and infection assay. Transfection of AcMNPV bacmid contain-
ing HearNPV f or mutant f was performed on Sf21 cells as described previously
(28, 30). Briefly, Sf21 cells were seeded in plastic petri dishes, 5 cm in diameter,
with 1  106 cells per dish. After 24 h of incubation in Grace’s insect medium
supplemented with 10% FBS, cells were washed twice with Grace’s insect me-
dium. Then, cells were transfected with approximately 1 g bacmid DNA dis-
solved in 12 l Lipofectin (Invitrogen). Supernatants, containing BVs, were
harvested 7 days posttransfection. Following an endpoint dilution assay (EPDA)
on Sf21 cells to determine the 50% tissue culture infective dose (TCID50) units
of the obtained AcMNPVs, secondary infections were performed at a multiplicity
of infection (MOI) of 5 TCID50/cell. Purified AcMNPV BV samples and infected
cells were subjected to Western analysis (28).
To produce HearNPV f or mutant f-pseudotyped gp64-null AcMNPV, trans-
fections of these pseudotyped bacmids were performed into Sf9Op1D cells con-
stitutively expressing Orgyia pseudotsugata MNPV (OpMNPV) GP64, instead of
Sf21 cells (see Fig. 5, below). Seven days posttransfection, supernatants contain-
ing pseudotyped gp64-null AcMNPV BVs carrying OpMNPV GP64 were used to
infect a new batch of Sf9Op1D cells to amplify these BVs. BV titers were deter-
mined with an EPDA on Sf21 cells, after which new Sf21 cells were infected by
these pseudotyped gp64-null AcMNPV BVs derived from Sf9Op1D cells at an
MOI of 5 TCID50/cell. Supernatants containing pseudotyped gp64-null AcM-
NPV BV derived from Sf21 cells were collected 5 days postinfection (p.i.). With
an EPDA on Sf21 cells, the infectivity of obtained pseudotyped gp64-null AcM-
NPV BV samples derived from Sf21 cells from these infections was determined.
The infected Sf21 cells were subjected to Western analysis (testing the presence
of HearNPV F and AcMNPV VP39 and the absence of AcMNPV GP64) and to
a low-pH-activated syncytium formation assay (26).
Western analysis. The expression of wild-type and mutant F proteins in Sf21
cells and their incorporation into AcMNPV BVs were examined by Western
analysis using polyclonal antibodies against F1 or F2 (28). Sucrose-purified BVs
or cellular total protein samples taken 48 h p.i. were subjected to Western
analysis as previously described (28). A polyclonal antibody against AcMNPV
VP39 (a gift from Pang Yi, Sun Yatsen University, Guangzhou, China) and a
monoclonal antibody against the GP64 AcV5 epitope (22) were used to detect
the presence of VP39 and GP64, respectively.
Budded virus production and syncytium formation assay. To investigate in-
fectious mutant f-pseudotyped AcMNPV BV production, Sf21 cells were in-
fected with pseudotyped AcMNPV, obtaining GP64 from Sf9Op1D cells at an
MOI of 5 TCID50/cell. After 48 h, for each treatment, triplicate supernatant
samples were collected and the quantity of infectious BVs from each sample was
determined in an EPDA on Sf21 cells. The experiments were done in triplicate,
and the results were exported to Microsoft Excel software and subjected to
statistical analysis. Pseudotyping AcMNPV BV budding efficiency was further
monitored by checking the average amount in 1.5 ml of released virus (pool of
the triplicate supernatant samples), as measured with VP39. The infected Sf21
cells were then used for Western analysis and syncytium formation assays.
Syncytium formation (Sf21-Sf21 fusion) assays were performed upon infection
of Sf21 cells with pseudotyped AcMNPV carrying GP64 from Sf9Op1D cells at an
MOI of 5 TCID50/cell (28). Forty-eight hours after infection, cells were washed
three times with 1 ml Grace’s medium (pH 6.1) without FBS and treated for 5
min in 1 ml acidic Grace’s medium at pH 5.0. Subsequently, the acidic medium
was removed and replaced with 2 ml Grace’s medium (pH 6.1) supplemented
with 10% FBS. Syncytium formation was observed by light microscopy 4 h after
acidification treatment.
Deglycosylation. Total proteins from AcMNPV-coding FL216R-infected Sf21
cells were separated by 12% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE). Small proteins ranging from 15 kDa to 20 kDa were
FIG. 2. Schematic diagram of pseudotyped AcMNPV bacmid construction. The signal peptide (SP), proteolytic cleavage site (❚), fusion peptide
(FP), heptad repeat (HR), transmembrane domain (TM), and cytoplasmic tail domain (CTD) are shown. Selected leucines (Leu209, Leu216, and
Leu223) were replaced with alanine or arginine, respectively. Donor plasmids carrying the HearNPV f cassette with the substitutions shown and
a p10 promoter-controlled egfp gene, used to mark infected cells, were used to construct pseudotyped AcMNPV bacmids.
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recovered from the gel by the syringe maceration extraction method (44) and
denatured by boiling for 10 min in the presence of 0.5% SDS and 1% of
-mercaptoethanol. Denatured proteins were incubated overnight either in
Endo H G5 buffer (50 mM sodium citrate, pH 5.5, 5 mM phenylmethylsulfonyl
fluoride) containing 1 U Endo H (New England Biolabs) or in PNGase F
incubation buffer (phosphate-buffered saline, pH 7.4, 20 mM EDTA, 0.5% NP-
40, 5 mM phenylmethylsulfonyl fluoride) containing 1 U PNGase F (Roche).
Deglycosylated proteins were separated by 12% SDS-PAGE followed by West-
ern analysis using polyclonal antibodies against F2.
RESULTS
HR1 region of baculovirus F proteins. To better understand
the architecture of baculovirus F proteins with respect to the
fusion peptide and the downstream-located HR region (HR1),
we aligned F proteins from members of group II NPV, granu-
lovirus (GV), and group I NPV (Ac23 homologs) (33) (Fig. 1).
The comparison of F proteins clearly showed the conserved
furin cleavage sites, fusion peptides, and the HR1 regions. In
agreement with a previous report, the areas of furin cleavage
and the adjacent fusion peptide are highly conserved among F
homologous proteins from group II NPVs and GVs (39, 51).
Also well-conserved is the HR1 region, located immediately
downstream of the fusion peptide (39). It is noteworthy that all
these conserved functional domains are present in F proteins
from group II NPVs and GVs, but none of these is found in the
truncated F or Ac23 homologs from group I NPVs (Fig. 1).
GP64 homologs are the functional envelope fusion proteins of
group I NPVs, not the truncated F homologs. This alignment
thus showed that F homologs from group I NPVs did not
contain the hallmark elements for a functional class I fusion
protein, which explains why the F homologs from group I
NPVs are nonfunctional envelope fusion proteins (33). Con-
served leucines are frequently found at the “d” position of the
HR1 region. Such leucine zipper-like HRs are commonly iden-
tified from other class I envelope fusion proteins, e.g., from
vertebrate viruses, and have been proved to be critical for
fusion activity and virus infectivity (7, 12, 14, 33, 41, 54).
Expression of F protein mutants in Sf21 cells. To see
whether the expression of F proteins was affected by mutations
in conserved leucines in HR1, we transposed all the mutated f
genes into an AcMNPV bacmid already encoding GP64 (Fig.
2). Transfection and infection experiments were performed to
obtain AcMNPVs carrying mutant f genes as previously de-
scribed (32). Three days postinfection, infected cells were col-
lected and the total cellular protein from each infection was
subjected to Western analysis using antibody against HearNPV
F1 and F2 separately (Fig. 3A). Expression of GP64 (lower
panel) was also tested as a loading control. Under reducing
conditions, F1 (upper panel) and F2 (middle panel) subunits
were detected in all samples, suggesting all six mutant F pro-
teins are not only expressed but also are expressed at a similar
level in AcMNPV-infected Sf21 cells as the parental F protein
(left lane). The furin-like cleavage of F proteins also properly
occurred with any of the substituted leucine residues in HR1,
as the subunits F1 and F2 migrated separately in all cases.
Surprisingly, the synthesis of F2 subunits of all the mutant F
proteins was affected (Fig. 3A, middle panel). Rather than
having two species of F2 subunits (unglycosylated [ugF2] and
major glycosylated F2 [gF2]as minor and major bands, respec-
tively), as in the case of parental F protein (leftmost lane),
three species of F2 subunits were found in mutant F proteins.
The third one (higher glycosylated F2 [hgF2]) appeared to be
around 2 kDa heavier than the unglycosylated form of F2 (Fig.
3A, middle panel). Especially in the case of FL216R, a substan-
tial amount of the heavier F2 was detected, whereas little or no
unglycosylated F2 could be detected in this case. These results
suggested that the expression and proteolytic processing of
wild-type and mutant F proteins were similar but that the
N-linked glycosylation pattern of the F2 subunit is considerably
changed as a consequence of the Leu substitutions in F1.
As the mutations were introduced in the HR1 region located
in the large F1 subunit, the molecular mass of F2 subunits
should presumably stay the same. However, for a minor por-
tion of the F2 subunits, the N-linked glycosylation appears to
be changed. There is only one genuine N-linked glycosylation
site in the F2 subunit (31). The most likely explanation is that
the N-linked glycosylation pattern of the F2 subunit is some-
how affected by the introduction of mutations in HR1 of F1.
The large N-linked glycans from the FL216R F2 subunit might
be an Endo H-sensitive form (oligomannose). To study the
characteristics of the larger F2, a deglycosylation assay was
performed on F2 recovered from SDS-PAGE (Fig. 3B). It was
found that the larger and glycosylated F2 subunits were sensi-
tive to PNGase treatment (lane 4), resulting in a single band
with similar molecular size to the F2 without N-linked glyco-
sylation (lane 1). Neither the mobility of F2 nor the glycosyla-
tion of F2 was sensitive to Endo H treatment, suggesting that
the larger N-linked glycan is not of the high-mannose type
(Fig. 3B, lane 5). This observation further suggested that the
mutations in conserved leucines in the HR1 region caused
changes in N-linked glycan processing in the F2 subunit, al-
though the majority of F2 is glycosylated as gF2, like the wild-
type F.
Incorporation of F protein mutants in AcMNPV. To further
study the effects of mutations of conserved leucine residues
in the HR1 region of HearNPV F protein on trafficking,
we examined the incorporation of mutated F proteins in
AcMNPV BVs. Proteins of sucrose-purified AcMNPV BVs
were separated by SDS-PAGE under reducing (Fig. 4A) or
nonreducing (Fig. 4B) conditions and were subsequently im-
mobilized on membranes for Western analysis. GP64 protein
was detected in all cases in almost equal amounts and served as
an internal control for the incorporation of F in BVs. Under
reducing conditions (Fig. 4A), F1 and F2 subunits were de-
tected separately in all BVs. This result is in agreement with
the previous finding that the furin-like cleavage of F protein is
not affected by mutating the conserved leucine residues (Fig.
3A). However, the incorporation level of the various mutant F
proteins in BVs is different; in particular, a much lower amount
of mutant FL216R was incorporated in mature BVs. Under
nonreducing conditions (Fig. 4B), both antibodies (against F1
and F2) detected F0 in the case of parental F protein. F0 was
also detected in the mutant F proteins except for BVs contain-
ing the FL216R protein. A significant amount of disulfide-linked
oligomer was detected in the case of FL216A, FL223A, and
FL216R proteins. The FL216R protein in monomeric form was
hardly detected as F0 but was present mainly as oligomers.
These results indicate that correct formation of disulfide bonds
is dependent on the conserved leucine residues in the HR1
region.
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HR1 of HearNPV F is important for HearNPV F to rescue
gp64-null AcMNPV and F fusogenicity. Based on findings de-
scribed in the previous sections, the mutant HearNPV F pro-
teins were found to be expressed in Sf21 cells and to be incor-
porated in AcMNPV BVs. To further understand correlations
between these mutations and F function, a novel testing system
was established to study the role of HR1 in the functionality of
F and F-mediated membrane fusion (Fig. 5). In this system,
HearNPV f/mutant f-pseudotyped gp64-null AcMNPV bac-
mids were transfected into Sf9Op1D cells constitutively express-
ing OpMNPV GP64 (38). The TCID50s of the obtained
pseudotyped AcMNPVs carrying both GP64 derived from
Sf9Op1D cells and F/mutant F were determined in an EPDA on
Sf21 cells. Then, Sf21 cells were infected with each GP64-
incorporated pseudotyped AcMNPV at the same MOI of 5
TCID50 units/cell. Infected Sf21 cells expressing no GP64 were
used for a low-pH-activated syncytium formation assay as a
result of the presence of a functional F, and the TCID50 of
progeny pseudotyped AcMNPV without GP64 incorporation
was determined in an EPDA on Sf21 cells again. A wild-type
AcMNPV bacmid and a gp64-null AcMNPV bacmid were in-
cluded in this system as a positive and a negative control,
respectively.
To show the potential of this novel test system, Western
analysis was carried out on pseudotype virus using HearNPV
F, AcMNPV VP39, and GP64 antibodies (Fig. 6A). HearNPV
F/mutant F proteins were found to be present in pseudotyped
AcMNPV-infected Sf21cells (lanes 3 to 9). AcMNPV major
capsid protein VP39 was found in all cases, including the gp64-
null AcMNPV (lane 3). The latter indicated that the GP64
FIG. 3. (A) Expression of the parental F and mutant F proteins by baculovirus (AcMNPV bacmid with its gp64 gene) in insect cells. Sf21 cells
were infected by AcMNPVs carrying parental f and mutant f cassettes. Forty-eight hours p.i., infected Sf21 cells were collected and lysed in
SDS-PAGE loading buffer. Total cellular proteins on a Western blot assay from each infection were probed by anti-F1 (upper), anti-F2 (middle),
and anti-GP64 (lower) antibodies under reducing conditions. (B) Deglycosylation assays of F2 from the F
L216R protein. Cellular proteins (ranging
from 25 kDa to 15 kDa) from AcMNPVgp64-/fL216R-infected Sf21 cells were recovered from an SDS-PAGE gel and were treated with Endo H and
PNGase F, respectively. F and FN104Q (an F2 N-linked glycan-negative mutant protein [31]) were used as controls.
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obtained from Sf9Op1D cells was able to bring gp64-null
AcMNPV BVs into Sf21 cells. GP64 was found only in wild-
type AcMNPV-infected Sf21 cells (lane 1) and not in gp64-null
AcMNPV cells (lane 2). This confirmed that Sf21 cells infected
with GP64-pseudotyped AcMNPV did not produce GP64. The
pseudotyped AcMNPV progeny from these infections did not
incorporate GP64 (Fig. 6A, upper panel), and these viruses
were suitable to test the infectivity of HearNPV f/mutant f
pseudotyped AcMNPV in Sf21 cells. These Western assay re-
sults confirmed the successful establishment of a new experi-
mental system to study baculovirus F functionality.
The HearNPV F protein is a functional analog of AcMNPV
GP64 (28). To determine the influence of leucine mutations in
HR1 on HearNPV F functionality, the infectious BV produc-
tion at 48 h p.i. was evaluated in EPDAs. HearNPV
f-pseudotyped AcMNPV produced much more infectious BVs
than all mutant f-pseudotyped AcMNPVs (Fig. 6B). EPDA
could not detect infectious virus from AcMNPV pseudotyped
FIG. 4. Incorporation of parental and mutant F proteins in AcMNPV-pseudotyped viruses. Western analysis was performed on purified
AcMNPV BVs carrying both F/F mutant proteins and GP64 by using anti-F1 (upper panel), anti-F2 (middle panel), and anti-GP64 (lower panel)
antibodies under either reducing conditions (A) or nonreducing conditions (B). GP64 detection under reducing conditions served as a proper
incorporation control.
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with the FL216R gene, suggesting that FL216R is not able to
rescue gp64-null AcMNPV. This result suggests that the con-
served leucines in HR1 are critical for the functionality of
HearNPV F and thus important for infectious pseudotyped
AcMNPV BV production. However, this could also be the
result of different efficiencies of pseudotyped AcMNPV BV
budding. To this end we checked the budding efficiency of
pseudotyped AcMNPV BV by testing the average amount of
VP39 released in supernatant containing each pseudotyped
AcMNPV BV. The results showed that F and mutant Fs me-
diate comparable BV budding, as evidenced by the amount of
VP39 (capsid protein) (Fig. 6B, lower panel). These results
further indicate that mutations in conserved leucines in HR1
do not change the production of pseudotyped AcMNPV BV,
but they affect the entry.
HR regions have been reported to play a critical role in class
I viral membrane fusion proteins. Baculoviruses enter host
cells through clathrin-mediated endocytosis (29). F protein
mediates fusion in late endosome upon low-pH activation. To
find out whether these conserved leucines in baculovirus F
protein HR1 are important for F fusogenicity, a low-pH-acti-
vated syncytium formation assay was conducted upon infection
of Sf21 cells with f/mutant f-pseudotyped AcMNPV where
GP64 was provided by the Sf9Op1D cells (Fig. 7). The results
showed that HearNPV with wild-type F mediated much more
significant syncytium formation (Fig. 7b) than the mutant Fs
(Fig. 7c to h). No syncytia were observed in the case of the
FL216R mutant, suggesting this mutant F protein is not able to
mediate fusion. This result strongly suggests that the leucines
in the HR1 region of HearNPV F are important for F-medi-
ated fusion and implies that the baculovirus F protein HR1
region plays a critical role in virus entry.
DISCUSSION
HR regions have been widely detected in membrane fusion
proteins of paramyxoviruses, influenza virus, coronaviruses,
and retroviruses and have been shown to play an essential role
in viral fusion and infectivity (15, 17). Structural studies of
membrane fusion proteins show that HR regions located in the
N terminus and C terminus of the fusion protein ectodomain
can form a coiled-coil six-helix bundle structure or the fusion
core (15). In the F protein from baculoviruses, a group of
invertebrate DNA viruses, we found three coiled-coil domains
in the F1 subunit of the HearNPV F protein (Fig. 2). The
similar architecture of baculovirus F proteins suggests that this
F protein is a class I virus fusion protein (16, 39), which is
usually found in vertebrate enveloped RNA viruses. In order to
understand the functional role of HR domains in baculovirus F
proteins, we studied the functional importance of HR1 by
site-directed mutagenesis of conserved leucines and reverse
genetics on three leucines at the d position in the HR1 domain.
These leucines, L209, L216, and L233, are likely involved in
formation of the six-helix bundle in analogy to vertebrate virus
F proteins.
In order to study the importance of these three nonpolar
leucines on the function of F, they were mutated into either
arginine (positively charged) or alanine (nonpolar) (Fig. 2).
The influences of these amino acid substitutions on F biosyn-
thesis and incorporation into virions were studied by using the
AcMNPV pseudotyping system in Sf21 cells (32). Mature bac-
ulovirus F proteins are located on BV particles as a homotri-
mer of F, in which F1 and F2 subunits are bridged by disulfide
bonds (24, 51). Three F proteins oligomerize as homotrimers
through noncovalent interactions (28, 52). Here we demon-
strated that on BV particles substitutions of selected leucines
within HR1 did not affect proteolytic processing of F but re-
sulted in multiple disulfide-linked oligomers (Fig. 4B). In par-
ticular, the L216R mutant protein hardly produced F12 as an
80-kDa protein, which is the hallmark of mature and functional
F on infectious BV particles (28, 52). This mutant also showed
no fusogenicity (Fig. 7g). Both antibodies against F1 and F2
subunits detected similar unusual disulfide-bridged oligomers
(Fig. 4B) in addition to the normal 80-kDa monomers, sug-
gesting that the disulfide bonding between F1 and F2 subunits
per se was not affected. Unusual disulfide bonds may be the
results of illegitimate oligomerization of mutant F proteins. It
is possible that these illegitimate oligomers were disulfide
bond-linked homotrimers of mutant F. It is equally possible
that they are hetero-oligomers consisting of mutant F and
other cellular or viral proteins. Nevertheless, these results sug-
gest that the conserved leucine zipper-like motif in HR1 is
important for proper folding and disulfide bond formation of
HearNPV F. A similar situation exists in paramyxoviruses,
where mutations destabilize the F protein and lead to mal-
folded multimers because of chemical cross-linking (18). In
addition, less protein was detected in AcMNPV BVs with
FL216R than with the other F mutant and authentic HearNPV
F proteins, which further suggests that a correct putative
coiled-coil conformation is also an important prerequisite for F
incorporation in BVs.
Like other virus envelope fusion proteins, baculovirus F is
also modified by N-linked glycosylation of both F1 and F2
FIG. 5. Schematic of the functional analysis of baculovirus F mu-
tants.
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subunits. It was confirmed by high-performance liquid chro-
matography and matrix-assisted laser desorption ionization–
time of flight mass spectrometry that the only potential N-
linked glycosylation site in the HearNPV F2 subunit (28) is
genuinely occupied most likely with paucimannose-type gly-
cans (S. P. Jongen and J. P. Kamerling, personal communica-
tion). Here we showed that replacement of selected leucine
residues at the “d” position in HR1 resulted in the attachment
of a heavier glycan on the F2 subunit, with an additional mo-
lecular mass of around 2 kDa, in addition to the major pauci-
mannose-type glycans. In particular, for the FL216R protein, a
significant amount of F2 with heavier glycans was detected
(Fig. 3A). Traces of F2 with heavier glycans were also detected
for the other five mutant F proteins (Fig. 3A), suggesting that
even a small change in F structure may result in a different type
of glycosylation. Compared to mammalian cells, insect cells
possess a truncated N-linked glycosylation pathway and hence
a paucimannose type of N-linked glycans, which are frequently
identified in mature glycoprotein expressed in insect cells (24).
However, the glycans observed in our (mutant) F protein were
not sensitive to Endo H treatment (Fig. 3B, lane 5), suggesting
that they are not of the oligomannose type. It may be possible
that the large N-linked glycans on F2 are the end product of
further extension on the GlcNacMan3GlcNac2Fuc structure.
We do not know yet the detailed structure of this heavier
glycan. Together with the observation of malformed disulfide
bond-bridged oligomers upon substitution of leucines in the
zipper, these observations also suggest that the conserved
leucines in baculovirus HR1 regions might be critical to F
biosynthesis. Further N-linked glycan profiling and lectin bind-
FIG. 6. gp64-null AcMNPV rescues the activity of HearNPV F/mutant F. (A) Western analysis of Sf21 cells infected by F-pseudotyped
AcMNPV grown in Op1D cells to obtain GP64 at an MOI of 5 TCID50/cell. Forty-eight hours p.i., expression of GP64, VP39, and HearNPV
F/mutant F was tested. (B) BVs from the supernatant of each infection treatment were collected. The infectivity in TCID50/ml was tested by using
Sf21 cells. Each data point represents infectious BV production at 48 h p.i. Error bars represent standard deviations from the means of triplicate
infections and titrations. Budding efficiency was monitored by testing the presence of BVs as evidenced by VP39.
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ing assays to determine the glycan structure will be necessary
and will contribute to the understanding of N-linked glyco-
protein quality control mechanisms in general in insect cells (6).
By utilizing the gp64-null AcMNPV pseudotyping system
(30), we demonstrated that conserved leucines in the HR1
region of HearNPV F are essential for rescuing the infectivity
of AcMNPV and for F fusogenicity. In addition, we showed a
variable but clear effect when individual leucine residues within
the HR1 region were replaced by either alanine or arginine
(summarized in Table 1). Both the alanine (nonpolar) and the
arginine (positively charged) substitution of Leu209 (nonpo-
lar) resulted in a dramatic decrease of rescued AcMNPV in-
fectivity and F fusogenicity, indicating that Leu209 is very
critical for F function. Leu209 is conserved at the “d” position
of the second repeat in HR1 in group II baculovirus F proteins,
but not in GV F proteins. The latter is also compatible with the
observation that the putative F protein from Plutella xylostella
GV is not able to rescue the infectivity of gp64-null AcMNPV
(32), as a threonine residue (polar, uncharged) was located at
the “d” position (Fig. 1). At the “a” position in the amphi-
pathic helix is a polar asparagine residue. Substitution of the
Leu209 with either alanine or arginine probably results in two
contiguous amino acid residues with small (Ala) or large (Arg)
side chains on the hydrophobic side of the coil. This possibly
destabilizes the interaction of HRs during six-helix bundle
formation or the prefusion stage (18) and results in strongly
reduced infectivity of L209A and L209R F mutants when
pseudotyped in AcMNPV.
Leu216 replaced by alanine resulted in a moderate decrease
of the F rescue activity and fusogenicity, whereas the replace-
ment of Leu216 with arginine led to a complete failure for
HearNPV F to rescue the infectivity of the gp64-null AcMNPV
or to mediate the low-pH-activated fusion, although BVs were
made (Fig. 6A, lane 8). According to the Berger algorithm (3),
among the six mutant F proteins the replacement of Leu216 by
arginine is the only one to abolish the coiled-coil structure of
the HR1 region, which is in good agreement with our results
showing no infectivity and no fusogenicity when FL216R was
tested in the AcMNPV pseudotyping system (Fig. 7g; Table 1).
The replacement of Leu223 with arginine (FL223R) resulted in
higher infectivity than the replacement of Leu223 with alanine
(FL223A). This might suggest that at the location of Leu223 the
size of the amino acid residue side chain is more important
than its polarity. These results again suggest that HR1 in bac-
ulovirus F is a critical determinant of F function.
Baculovirus BVs enter host cells through a clathrin-depen-
FIG. 7. Syncytium formation promoted by HearNPV F/mutant F. Sf21 cells were infected by gp64-null AcMNPV with F or mutant F and GP64
obtained from Op1D cells at an MOI of 5 TCID50/cell (panels b to h). An AcMNPV gp64-null mutant served as negative control for fusogenicity.
Forty-eight hours p.i., infected Sf21 cells were incubated in Grace’s insect medium (pH 5.0) for 5 min. After one wash with fresh Grace’s insect
medium, the cells were incubated in Grace’s insect medium plus 10% FBS. Syncytium formation was observed 12 h post-low-pH treatment.
TABLE 1. Summary of obtained results
F protein Coila Rescue Fusogenicity Cleavage Mass of N-glycans onF2 (kDa)
Detection of F0 Incorporation
F     1.1  
FL209A     1.1  
FL209R     1.1  
FL216A     1.1  
FL216R     1.1/2.0 / 
FL223A     1.1  
FL223R     1.1  
a Coil probability was predicted according to the Berger algorithm (3): , good; , fair; , bad. A significant amount of F2 from FL216R carries heavier
N-glycans (around 2.0 kDa), although the majority of F2 from FL216R carries paucimannose-type N-glycans (around 1.1 kDa).
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dent endocytosis, and the nucleocapsids are released upon a
low-pH-activated fusion (29) mediated by either GP64 (group
I) or F (group II). The HR region in GP64 plays a critical role
in GP64-mediated membrane fusion (26). Here, using reverse
genetics, we have shown that the conserved leucine residues
located in fusion peptide-proximal HR1 are important deter-
minants of baculovirus F fusogenicity, virus infectivity, and F
protein proper folding. However, they do not affect pseudotyp-
ing AcMNPV BV formation. HR1 and the leucines studied are
well-conserved in the F homologous proteins from group II
NPVs, whereas an HR1 region cannot be found in the F
homolog from group I NPVs, which posses the GP64 ortholog
as the functional envelope fusion protein (Fig. 1) (33). Testing
the fusogenicity of the putative GV F protein may require a
GV pseudotyping system. Our results further implicate that the
presence of the HR1 region in F homologs from group II
NPVs and GVs is a hallmark for a functional baculovirus F
protein.
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